Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | APEX nuclease (multifunctional DNA repair enzyme) 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | metacaspase, putative | 0.0171 | 0.2532 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Echinococcus granulosus | caspase 8 | 0.0171 | 0.2532 | 0.2532 |
Brugia malayi | mucosa associated lymphoid tissue lymphoma translocation protein 1 | 0.0171 | 0.2532 | 1 |
Giardia lamblia | Endonuclease/Exonuclease/phosphatase | 0.0023 | 0.0167 | 0.5 |
Trypanosoma brucei | metacaspase 5, putative | 0.0171 | 0.2532 | 1 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0171 | 0.2532 | 1 |
Trypanosoma brucei | metacaspase | 0.0171 | 0.2532 | 1 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0171 | 0.2532 | 1 |
Echinococcus granulosus | caspase | 0.0641 | 1 | 1 |
Treponema pallidum | exodeoxyribonuclease (exoA) | 0.0023 | 0.0167 | 0.5 |
Plasmodium vivax | metacaspase 1, putative | 0.0171 | 0.2532 | 1 |
Echinococcus multilocularis | caspase 3 | 0.0469 | 0.7274 | 0.7274 |
Wolbachia endosymbiont of Brugia malayi | exonuclease III | 0.0023 | 0.0167 | 0.5 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0171 | 0.2532 | 1 |
Trypanosoma brucei | metacaspase MCA3 | 0.0171 | 0.2532 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 0.2532 | 1 |
Echinococcus multilocularis | caspase 8 | 0.0171 | 0.2532 | 0.2532 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0171 | 0.2532 | 0.2532 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.2532 | 1 |
Loa Loa (eye worm) | exodeoxyribonuclease III family protein | 0.0023 | 0.0167 | 0.066 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 0.2532 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Mycobacterium tuberculosis | Probable exodeoxyribonuclease III protein XthA (exonuclease III) (EXO III) (AP endonuclease VI) | 0.0023 | 0.0167 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3061 | 0.3061 |
Trypanosoma brucei | metacaspase MCA2 | 0.0171 | 0.2532 | 1 |
Mycobacterium ulcerans | exodeoxyribonuclease III protein XthA | 0.0023 | 0.0167 | 0.5 |
Plasmodium falciparum | metacaspase 1 | 0.0171 | 0.2532 | 1 |
Entamoeba histolytica | exodeoxyribonuclease III, putative | 0.0023 | 0.0167 | 0.5 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0641 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0171 | 0.2532 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 0.2532 | 1 |
Echinococcus granulosus | geminin | 0.0205 | 0.3061 | 0.3061 |
Leishmania major | metacaspase, putative | 0.0171 | 0.2532 | 1 |
Toxoplasma gondii | ICE family protease (caspase) p20 domain-containing protein | 0.0171 | 0.2532 | 1 |
Echinococcus granulosus | caspase 2 | 0.0171 | 0.2532 | 0.2532 |
Plasmodium falciparum | metacaspase-like protein | 0.0171 | 0.2532 | 1 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0171 | 0.2532 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.3061 | 0.3061 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Echinococcus granulosus | caspase 3 | 0.0469 | 0.7274 | 0.7274 |
Trypanosoma cruzi | metacaspase, putative | 0.0171 | 0.2532 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0023 | 0.0167 | 0.0167 |
Echinococcus granulosus | DNA apurinic or apyrimidinic site lyase | 0.0023 | 0.0167 | 0.0167 |
Brugia malayi | exodeoxyribonuclease III family protein | 0.0023 | 0.0167 | 0.066 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Echinococcus multilocularis | DNA (apurinic or apyrimidinic site) lyase | 0.0023 | 0.0167 | 0.0167 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 0.2532 | 1 |
Echinococcus multilocularis | geminin | 0.0205 | 0.3061 | 0.3061 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Schistosoma mansoni | subfamily C14A unassigned peptidase (C14 family) | 0.0171 | 0.2532 | 0.2532 |
Plasmodium vivax | hypothetical protein, conserved | 0.0171 | 0.2532 | 1 |
Trypanosoma cruzi | metacaspase, putative | 0.0171 | 0.2532 | 1 |
Echinococcus multilocularis | caspase 2 | 0.0171 | 0.2532 | 0.2532 |
Brugia malayi | Cell death protein 3 precursor | 0.0171 | 0.2532 | 1 |
Echinococcus multilocularis | caspase 3, apoptosis cysteine peptidase | 0.0641 | 1 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Schistosoma mansoni | caspase-3 (C14 family) | 0.0641 | 1 | 1 |
Trypanosoma cruzi | metacaspase 5, putative | 0.0171 | 0.2532 | 1 |
Schistosoma mansoni | ap endonuclease | 0.0023 | 0.0167 | 0.0167 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 0.2532 | 1 |
Trichomonas vaginalis | Clan CD, family C14, metacaspase-like cysteine peptidase | 0.0171 | 0.2532 | 1 |
Echinococcus multilocularis | caspase | 0.0641 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 0.2532 | 1 |
Trypanosoma brucei | Metacaspase-4 | 0.0171 | 0.2532 | 1 |
Trypanosoma cruzi | metacaspase, putative | 0.0171 | 0.2532 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 0.0000597 uM | PubChem BioAssay. qHTS Assay for Inhibitors of the Human Apurinic/apyrimidinic Endonuclease 1 (APE1). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 0.2311 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 2.5119 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] | ChEMBL. | No reference |
Potency (functional) | = 6.3096 um | PUBCHEM_BIOASSAY: qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 100 um | PUBCHEM_BIOASSAY: qHTS Inhibitors of AmpC Beta-Lactamase (assay with detergent). (Class of assay: confirmatory) [Related pubchem assays: 1002 (Confirmation Concentration-Response Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent)), 585 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay without detergent) - a screen old NIH MLSMR collection), 584 (Promiscuous and Specific Inhibitors of AmpC Beta-Lactamase (assay with detergent) - a screen of the old NIH MLSMR collection), 1003 (Confirmation Cuvette-Based Assay for Inhibitors of AmpC Beta-Lactamase (assay with detergent))] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.